Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study | Zendy

Craig S. Jabaley | Zendy; Francis Wolf | Zendy; Grant C. Lynde | Zendy; Vikas N. O’Reilly-Shah | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study

Author(s) -

Craig S. Jabaley,

Francis Wolf,

Grant C. Lynde,

Vikas N. O’Reilly-Shah

Publication year - 2018

Publication title -

therapeutic advances in drug safety

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.196

H-Index - 32

eISSN - 2042-0994

pISSN - 2042-0986

DOI - 10.1177/2042098618769565

Subject(s) - sugammadex , medicine , observational study , adverse effect , crowdsourcing , pharmacology , rocuronium , world wide web , computer science , propofol

Mobile applications (apps) have become a ubiquitous source of clinical decision support. We sought to ascertain the feasibility of using an app platform to obtain a crowdsourced measure of adverse drug reaction reporting rates associated with sugammadex administration and compare it with traditionally-derived estimates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research